Ellen Plasschaert

845 total citations
15 papers, 583 citations indexed

About

Ellen Plasschaert is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ellen Plasschaert has authored 15 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Ellen Plasschaert's work include Neurofibromatosis and Schwannoma Cases (14 papers), Vascular Malformations Diagnosis and Treatment (6 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Ellen Plasschaert is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (14 papers), Vascular Malformations Diagnosis and Treatment (6 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Ellen Plasschaert collaborates with scholars based in Belgium, Netherlands and United States. Ellen Plasschaert's co-authors include Eric Legius, Mie‐Jef Descheemaeker, Ilse Noens, Lien Van Eylen, Jean Steyaert, Annick Vogels, Shruti Garg, Jonathan Green, Susan Huson and Ype Elgersma and has published in prestigious journals such as Neurology, The Lancet Neurology and Journal of Autism and Developmental Disorders.

In The Last Decade

Ellen Plasschaert

15 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Plasschaert Belgium 12 396 195 177 136 87 15 583
Lianne C. Krab Netherlands 9 298 0.8× 172 0.9× 190 1.1× 113 0.8× 43 0.5× 11 543
Shelley Hyman Australia 9 957 2.4× 529 2.7× 161 0.9× 141 1.0× 83 1.0× 10 1.1k
Morinobu Seki Japan 15 609 1.5× 83 0.4× 142 0.8× 56 0.4× 75 0.9× 47 810
Mie‐Jef Descheemaeker Belgium 16 596 1.5× 277 1.4× 235 1.3× 337 2.5× 155 1.8× 20 989
Tena Rosser United States 19 597 1.5× 266 1.4× 233 1.3× 185 1.4× 88 1.0× 43 1.1k
Veronica Saletti Italy 16 156 0.4× 95 0.5× 151 0.9× 152 1.1× 84 1.0× 50 832
Dominique J. Verlaan Canada 12 327 0.8× 66 0.3× 224 1.3× 122 0.9× 35 0.4× 13 655
Estefanía Torres-Vega Spain 5 472 1.2× 71 0.4× 114 0.6× 77 0.6× 40 0.5× 9 589
Mark B. Skeen United States 8 705 1.8× 114 0.6× 207 1.2× 198 1.5× 23 0.3× 21 1.1k
Emin Cumhur Şener Türkiye 15 112 0.3× 175 0.9× 395 2.2× 184 1.4× 88 1.0× 38 1.0k

Countries citing papers authored by Ellen Plasschaert

Since Specialization
Citations

This map shows the geographic impact of Ellen Plasschaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Plasschaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Plasschaert more than expected).

Fields of papers citing papers by Ellen Plasschaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Plasschaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Plasschaert. The network helps show where Ellen Plasschaert may publish in the future.

Co-authorship network of co-authors of Ellen Plasschaert

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Plasschaert. A scholar is included among the top collaborators of Ellen Plasschaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Plasschaert. Ellen Plasschaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Borrie, Sarah C., Ellen Plasschaert, Zsuzsanna Callaerts‐Vegh, et al.. (2021). MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders. Molecular Autism. 12(1). 53–53. 10 indexed citations
2.
Rietman, André B., Sabine E. Mous, Ellen Plasschaert, et al.. (2020). Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genetics in Medicine. 22(5). 889–897. 23 indexed citations
3.
Rietman, André B., Thijs van der Vaart, Ellen Plasschaert, et al.. (2017). Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 177(3). 319–328. 18 indexed citations
4.
Eylen, Lien Van, Ellen Plasschaert, Johan Wagemans, et al.. (2017). Visuoperceptual processing in children with neurofibromatosis type 1: True deficit or artefact?. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 174(4). 342–358. 9 indexed citations
5.
Plasschaert, Ellen, Lien Van Eylen, Mie‐Jef Descheemaeker, et al.. (2016). Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(3). 348–362. 41 indexed citations
6.
Cassiman, Cathérine, Ingele Casteels, Julie A. Jacob, et al.. (2016). Choroidal abnormalities in café‐au‐lait syndromes: a new differential diagnostic tool?. Clinical Genetics. 91(4). 529–535. 15 indexed citations
7.
Morris, Stephanie M., Maria T. Acosta, Shruti Garg, et al.. (2016). Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1. JAMA Psychiatry. 73(12). 1276–1276. 80 indexed citations
8.
Vaart, Thijs van der, André B. Rietman, Ellen Plasschaert, et al.. (2015). Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology. 86(2). 154–160. 25 indexed citations
9.
10.
Garg, Shruti, Ellen Plasschaert, Mie‐Jef Descheemaeker, et al.. (2014). Autism Spectrum Disorder Profile in Neurofibromatosis Type I. Journal of Autism and Developmental Disorders. 45(6). 1649–1657. 53 indexed citations
11.
Plasschaert, Ellen, Karen Caeyenberghs, Guy Vingerhoets, et al.. (2014). Deficient motor timing in children with neurofibromatosis type 1. Research in Developmental Disabilities. 35(11). 3131–3138. 9 indexed citations
12.
Plasschaert, Ellen, Mie‐Jef Descheemaeker, Lien Van Eylen, et al.. (2014). Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 168(1). 72–80. 83 indexed citations
13.
Vaart, Thijs van der, Ellen Plasschaert, André B. Rietman, et al.. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. The Lancet Neurology. 12(11). 1076–1083. 89 indexed citations
14.
Descheemaeker, Mie‐Jef, Ellen Plasschaert, Jean‐Pierre Frijns, & Eric Legius. (2012). Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group. Journal of Intellectual Disability Research. 57(9). 874–886. 35 indexed citations
15.
Denayer, Ellen, Mie‐Jef Descheemaeker, Douglas R. Stewart, et al.. (2011). Observations on intelligence and behavior in 15 patients with Legius syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 157(2). 123–128. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianne C. Krab Breakdown of academic impact, for papers by Shelley Hyman Breakdown of academic impact, for papers by Morinobu Seki Breakdown of academic impact, for papers by Mie‐Jef Descheemaeker Breakdown of academic impact, for papers by Tena Rosser Breakdown of academic impact, for papers by Veronica Saletti Breakdown of academic impact, for papers by Dominique J. Verlaan Breakdown of academic impact, for papers by Estefanía Torres-Vega Breakdown of academic impact, for papers by Mark B. Skeen Breakdown of academic impact, for papers by Emin Cumhur Şener
Rankless by CCL
2026